FINWIRES · TerminalLIVE
FINWIRES

Marksans Pharma's Consolidated Net Profit Jumps in Fiscal Q4; Shares Jump 7%

By

Marksans Pharma's (NSE:MARKSANS, BOM:524404) consolidated attributable net profit rose to 1.48 billion Indian rupees in the fiscal fourth quarter ended March 31, from 905.5 million rupees a year ago.

Earnings per share climbed to 3.27 rupees from 2.00 rupees a year earlier, the pharmaceutical company said in a filing to the Indian stock exchanges on Tuesday.

Revenue from operations in fiscal Q4 also increased to 8.56 billion rupees from 7.08 billion rupees a year ago.

The company's board recommended a final dividend of 0.90 rupees per equity share of face value of 1 rupee per share for the fiscal year ended March 31.

The company's shares were up nearly 7% in recent trade.

Related Articles

Asia

CIAN Agro Industries' Consolidated Net Profit Jumps in Fiscal Q4; Shares Up 5%

CIAN Agro Industries & Infrastructure's (BOM:519477) consolidated attributable net profit surged to 639.3 million Indian rupees in the fiscal fourth quarter ended March 31 from 83.6 million rupees a year ago.Earnings per share soared to 22.84 rupees from 2.99 rupees a year earlier, the agro-processing company said in a filing to the BSE on Tuesday.Revenue from operations in fiscal Q4 also increased to 6.56 billion rupees from 4.90 billion rupees a year ago.The company's shares were up 5% in recent trade.

$BOM:519477
Asia

Heren Health Shares Suspend Trading Amid Potential Control Change

Heren Health (SHE:300550) shares on Tuesday suspended trading for up to two days amid a potential change in control.Controlling shareholders and major shareholder Topchoice Medical Corporation are planning a matter that could lead to a change in corporate control, according to a Tuesday filing with the Shenzhen bourse.

$SHE:300550
Asia

Petronas to Take Full Ownership of Joint Venture with Saudi Aramco

Petroliam Nasional (PETRONAS) agreed to acquire Saudi Aramco's stakes in Pengerang Refining and Pengerang Petrochemical, collectively known as PRefChem, according to a Monday press release.Subject to closing conditions, the deal will make the joint venture a wholly owned unit of PETRONAS.The acquisition will boost operational alignment and flexibility across PRefChem's value chain, PETRONAS said.Both companies said they will continue exploring commercial cooperation, including crude supply coordination, technology exchange, and product distribution.

$^KLSE